Current Price
JENA-R is an innovative biotechnology firm focused on developing cutting-edge therapeutic solutions for complex medical challenges. With a diverse pipeline of drug candidates in various stages of clinical trials, the com...|
e.g. Promoter holding
Loading chart...
Analyst consensus EPS and Revenue forecasts.
Earnings estimates are not available for this company.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AAbony Acqu... | AACOU | — | — | — | — | — | — | — |
| 2. | AApogee Acq... | AACPU | — | — | — | — | — | — | — |
| 3. | AAres Acqui... | AACTWS | — | — | — | — | — | — | — |
| 4. | AAres Acqui... | AAC-U | — | — | — | — | — | — | — |
| 5. | AAres Acqui... | AAC-WS | — | — | — | — | — | — | — |
Consolidated Figures in Millions / View Standalone.
| Quarter (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Revenue |
COGS |
Gross Profit |
Gross Profit % |
EBIT |
OPM % |
Non-Operating Income |
PBT |
Income Tax |
Tax Rate % |
Net Income |
NPM % |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Total Assets |
Total Liabilities |
Consolidated Figures in Millions / View Standalone.
| Period (M) |
|---|
Net CFNet Cash Flow |
FCFFree Cash Flow |
Financial ratios and valuation metrics by fiscal year.
| Period |
|---|
Cash Conversion |
Payout Ratio |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Who owns Jena Acquisition Corporation II Rights each right to acquire onetwentieth 120 of one Class A ordinary share, from SEC filings
No SEC ownership filings for this company yet.
Jena Acquisition Corporation II Rights each right to acquire onetwentieth 120 of one Class A ordinary share's SEC filings and earnings call transcripts
No SEC filings for this company yet.
What recent news says about Jena Acquisition Corporation II Rights each right to acquire onetwentieth 120 of one Class A ordinary share, scored for sentiment.